ATLANTA--(BUSINESS WIRE)--Sciele Pharma, Inc. (NASDAQ:SCRX):
Fourth quarter 2006 financial results include:
Revenues were $79.5 million, an increase of 19% over fourth quarter of 2005
Diluted earnings per share were $0.38, an increase of 19% over fourth quarter of 2005
EBITDAS(a), a non-GAAP measure, was $26.9 million
Cash flow per share(b), a non-GAAP measure, was $0.53
